Company News
Location:
Home
News
Company News
Laviana was named the most investment value of the project


Capital pool, determined to innovate - a dream factory opened smoothly!
The following articles are reproduced from the medical geography



September 1, 2017 (34th) National Pharmaceutical Industry Information Annual Meeting "Rongchuang DreamWorks" successfully held. "Fortune DreamWorks" by the China Pharmaceutical Industry Information Center, for entrepreneurs, investors and entrepreneurs to provide a medical and health industry investment and financing project road and docking platform.

China Pharmaceutical Industry Information Center senior industry researcher Tao Xuhui served as the meeting presided over the meeting guests have the Chinese medicine health industry fund partner Zeng Zhiqiang, Hua Li Pharmaceutical Group Co., Ltd. Wang Siyang, vice president of Asia Pharmaceutical Group Co., Ltd. Ren Wei, Co., Ltd. Chairman Chen Yonghong, Long Xin Health Industry Co., Ltd. President Shen Wenqiu, Shanghai Hyundai Pharmaceutical Co., Ltd. Vice President Wei Dongsong, HT Investment partner Si Ting You and Gao Tejia Investment Group Managing Partner Hu Xuefeng and so on.


First of all, the project roadshow, five entrepreneurs for a wonderful investment and financing projects, and guests on the issues raised. Subsequently, the judges from the scene of the eight guests and more than 30 representatives of the investment agency on behalf of the composition of the assessment, the project name and score are as follows:

After the comprehensive evaluation of the jury, R & D Pharmaceutical (Jiangsu) Co., Ltd. "CDMO pharmaceutical custom R & D and production" was named the most investment value of the project; US Medical Technology Co., Ltd. a "non-invasive blood glucose monitoring system" and the United States Biotechnology Co., Ltd. "fourth-generation CAR-T treatment of glioblastoma" was named the most investment potential of the project; Wuxi Medical Software Technology Co., Ltd. "medical library medical education platform" and Fujian Tiantai Pharmaceutical Technology Co., Ltd. "P75ECD-FC human recombinant protein research and development" project also by the jury approved.

Followed by a roundtable dialogue entitled "The next five years of major health investment trends and trends", which was hosted by Eric Tsang, Wang Siyang, Ren Wei, Chen Yonghong, Shen Wenqiu, Wei Dongsong, Si Tingyou and Hu Xuefeng Drug innovation, pharmaceutical industry investment and financing and mergers and acquisitions and other topics to start a lively discussion. Zeng Zhiqiang concluded: "Innovation and mergers and acquisitions is the development of the two wheels, capital and industry is an indispensable part of the development of the country, entrepreneurs, entrepreneurs and investors together, will be for the health of the health industry Development made a great contribution. "


The meeting is the final project docking link, five entrepreneurs can make more details of the road project and guests one-on-one exchange, in order to achieve the purpose of seeking investment and financing, or get the guests valuable advice.